Thyroid Hormone Diseases and Osteoporosis.

Area of Science:

• Endocrinology
• Bone Metabolism
• Mineralocorticoid Physiology

Background:

• Thyroid hormones are crucial for skeletal development and adult bone metabolism.
• Thyroid dysfunction, particularly hyperthyroidism, can adversely affect bone structure and mass.
• Subclinical hyperthyroidism, often asymptomatic, is increasingly recognized for its potential impact on bone health.

Purpose of the Study:

• To review the effects of thyroid dysfunction on bone metabolism and bone mineral density (BMD).
• To investigate the association between subclinical hyperthyroidism and osteoporosis risk.
• To explore the impact of exogenous subclinical hyperthyroidism from thyroxine therapy on BMD.

Main Methods:

• Literature review of studies examining thyroid hormones and bone health.
• Analysis of data on bone turnover markers and BMD in hyperthyroid and hypothyroid states.
• Evaluation of TSH-suppressive thyroxine therapy effects on bone.

Main Results:

• Severe hyperthyroidism is linked to high bone turnover osteoporosis.
• Subclinical hyperthyroidism may decrease BMD and increase fracture risk, particularly in postmenopausal women.
• Long-term TSH-suppressive thyroxine therapy can reduce BMD and increase fracture risk in postmenopausal women.

Conclusions:

• Thyroid dysfunction significantly influences bone metabolism, with subclinical hyperthyroidism posing a risk for decreased BMD and fractures.
• Postmenopausal women are particularly susceptible to the adverse bone effects of thyroid dysfunction and thyroxine therapy.
• The precise cellular and molecular mechanisms of thyroid hormone action on bone require further elucidation.